-
|
|
| |
- Identify
the upcoming and leading top 25+ high-growth
privately held medtech companies in Europe.
-
Introduce those companies to key European, US
and Asian investors and professionals who
can assist in their global expansion.
- Generate
deals amongst participants.
- Promote
new technologies.
|
| |
|
|
|
| |
A group of highly
regarded European professionals is undertaking the
responsibility of screening and selecting the
companies. A selection committee purpose is to ensure
the independence of the selection process.
The Selection Committee includes:
- Daniel Bertholet, Endeavour Vision
- Jean-Frederic Berthoud, Canton Vaud
- Johan Christenson, HealthCap
- Aris Constantinides, NBGI Ventures
- Arnaud Delhaye, Medtronic
- Annegret de Baey-Diepolder, GIMV
- Maciek Drozdz, Entrepreneurs Fund
- Thomas Goebel, NeoMed Management
- Tim Haines, Abingworth
- Gérard Hascoet, MD Start
- Brian Hashemi, IJ Partners SA -
Chairman Medtech Summit 2010
- Urs Hofmeier, Linde Healthcare
- Anja Koenig, Novartis
- Avi Molcho, Forbion
- Bill Muirhead - President Medtech
Summit 2010
- Antoine Papiernik, Sofinnova - VP
Selection Committee Medtech Summit 2010
- Thom Rasche, Earlybird Venture Capital
- Manus Rogan, FH Partners
- Peter Ruppersberg, Valtronic Technologies
- Josep Lluis Safeliu, Ysios Capital Partners
- Rainer Strohmenger, Wellington Partners
- Jay Watkins, Denovo
- Barry Wilson, Global Healthcare Adviser
- Raphael Wisniewski, Edmond de
Rothschild Investment Partners
|
| |
|
|
|
| |
| A list of the companies
that are selected to present during the Medtech Summit
will be available on September 29th for delegates only
or on the website 1-2 months post event date. |
|
|
|
